Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 7Other neoplasm 4Gastrointestinal 2Tumor-Agnostic 1Thoracic 1

Conditions

Rectal Neoplasms 2Precancerous Conditions 2Colorectal Neoplasms 2Colonic Neoplasms 2Adenomatous Polyps 2

Interventions

Fluorouracil 308Oxaliplatin 259Leucovorin 233Capecitabine 198Irinotecan 145Gemcitabine 127Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 63Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 41S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36Surgical Procedures, Operative 27130-nm albumin-bound paclitaxel 27regorafenib 25lenvatinib 24XELOX 24Panitumumab 24Radiation 23Nivolumab 22trifluridine tipiracil drug combination 21atezolizumab 21Carboplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Selenium × Gastrointestinal × Clear all
NCT00706121 2019-12-16

ACP

SWOG Cancer Research Network

Phase 3 Completed
8,094 enrolled 23 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

NCT00078897 2019-09-24

Selenium for Prevention of Adenomatous Colorectal Polyps

University of Arizona

Phase 3 Terminated
1,621 enrolled 12 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡